Q2 2023 13F Holders as of 30 Jun 2023
-
Type / Class
-
Equity / Common Shares
-
Shares outstanding
-
80,058,224
-
Total 13F shares
-
3,867,050
-
Share change
-
-73,937
-
Total reported value
-
$13,804,517
-
Put/Call ratio
-
6%
-
Price per share
-
$3.57
-
Number of holders
-
73
-
Value change
-
-$152,452
-
Number of buys
-
18
-
Number of sells
-
22
Institutional Holders of Mind Medicine (MindMed) Inc. - Common Shares (MNMD) as of Q2 2023
As of 30 Jun 2023,
Mind Medicine (MindMed) Inc. - Common Shares (MNMD) was held by
73 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
3,867,050 shares.
The largest 10 holders included
Alyeska Investment Group, L.P., VANGUARD GROUP INC, BlackRock Inc., GEODE CAPITAL MANAGEMENT, LLC, Busey Wealth Management, CHARLES SCHWAB INVESTMENT MANAGEMENT INC, Cresset Asset Management, LLC, TWO SIGMA INVESTMENTS, LP, STATE STREET CORP, and Data Collective IV GP, LLC.
This page lists
76
institutional shareholders reporting positions in this security
for the Q2 2023 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.